Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)
Millennials tend to want less regulation, while Gen Z leans toward more
Tabatabaei SN, Derbali RM, Yang C, Superstein R, Hamel P, Chain JL, et al
Anti-methamphetamine monoclonal antibodies have completed Phase 1 trials showing acceptable safety profiles
They are not effective, have little scientific evidence to back up their claims, and are misleading because they do not contain any GLP-1 agonists
Take your time, especially during those first few reconstitutions